Images

Proseek Multiplex Detects Cancer Biomarkers in Fraction of a Drop of Blood

Mar 12, 2013 08:56 EDT Olink Bioscience Proseek Multiplex Oncology I 96x96 is a next generation multivariate protein biomarker detection kit. It uniquely allows multiplexing of immunoassays without compromising assay performance. Proseek simultaneously quantifies up to 92 proteins in just 1 μL liquid samples such as serum and plasma with exceptional analytical performance.

Swedish Innovation Enables Quantification of 92 Proteins in Just One Microliter Sample

Mar 12, 2013 08:53 EDT Olink Bioscience Olink introduces a new generation of multiplexed protein biomarker immunoassays. Until now, it has been impossible to scale up conventional assays due to increased antibody cross-reactivity when large numbers of assays are run simultaneously. With Proseek Multiplex, biomarker researchers can quantify 92 proteins in just one microliter sample without compromising data quality or performance.

Olivier Duchamps, Conference Director, Nordic Life Science Days

Feb 01, 2013 03:00 EST SwedenBIO SwedenBIO produces the international invest- partner- and networking meeting Nordic Life Science Days, at Stockholm Waterfront on Oct 14,15. See nlsdays.com

Olivier Duchamps, Conference Director, Nordic Life Science Days

Feb 01, 2013 03:00 EST SwedenBIO SwedenBIO produces the international invest- partner- and networking meeting Nordic Life Science Days, at Stockholm Waterfront on Oct 14,15. See nlsdays.com

Life Science by SwedenBIO - an industry with extremely high potential

Mar 22, 2012 13:30 EDT SwedenBIO ”Life Science" by SwedenBIO will be distributed at the upcoming Life Science Investment Day Scandinavia on March 27, Scandinavia's largest international business meeting for life science. Life Science highlights from start to finish various stages from basic research to final treatment methods and how many players it takes to complete a process that can take a decade or more.

Jonas Ekstrand SwedenBIO arranges Life Science Investment Day Scandinavia

Mar 16, 2012 15:07 EDT SwedenBIO “We know that meetings such as Life Science Investment Day Scandinavia enable the very survival of several companies,” says SwedenBIO’s head of business development and finance Jonas Ekstrand, who organizes the event. “Our aim is to have a new Pharmacia and Astra, so points of contact such as this event are one of many ways for us to help.” #LSID 2012

Johan Järte, CEO SwedenBIO arranges Life Science Investment Day Scandinavia

Mar 16, 2012 15:04 EDT SwedenBIO “Sweden is a prestigious country in life science,” says SwedenBIO CEO Johan Järte, “and we envisage significant interest in us from global companies. For our members to have the best environment to develop and remain in Sweden requires cooperation on all fronts: regionally and internationally, between different professional categories and cross-industry alliances.” #LSID 2012

Thomas Olin, CEO Kancera - presenting company at Life Science Investment Day Scandinavia

Mar 16, 2012 15:03 EDT SwedenBIO "Life Science Investment Day Scandinavia is the most important business-oriented life science meeting in Sweden, “says Kancera CEO Thomas Olin. “Having an international meeting on our own territory is extremely important to visualize the quality and breadth of our research and development. It is one of the few meetings where we can attract a critical mass of investors and corporations.” #LSID 2012

Ageology Dr. Paul Savage Contributed to Suzanne Somers New York Times Best Seller: Ageless

Feb 17, 2012 16:11 EST Ageology When Suzanne Somers was researching doctors specializing in bioidentical hormone therapy, she reached out to Dr. Paul Savage and his expertise in nutrition and hormones.

Women's World Interviews Ageology Dr. Paul Savage

Feb 17, 2012 15:54 EST Ageology Woman's World Magazine, a weekly magazine with a circulation of 1.6 million readers, turned to Dr. Paul Savage in a 2006 story about how bioidentical hormone therapy can help treat women suffering from PMS.